Avastin promising in ovarian cancer
June 7, 2010Research and Development ASCO, avastin
Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …
Pfizer recalls Indian-made intravenous drugs
June 7, 2010Manufacturing and Production Claris Lifesciences, Pfizer, manufacturing compliance, recalls
Pfizer is recalling two intravenous antibiotics and an anti-nausea medication after particulate matter was found to be floating in them, leading …
Teva will invest $56m in Canadian plant
June 7, 2010Manufacturing and Production Canada, Teva, production
Israeli generic drugmaker Teva Pharmaceutical Industries is planning to spend $54 million to expand a Canadian production plant for solid …
Careers Voice: Online recruitment? Don’t take it at face value
June 7, 2010Business Services careers voice, rsa
With social networking and online sites offering low cost solutions, are the days of traditional recruitment firms numbered? Without face-to-face …
UCB’s Kola joins Astex board
June 5, 2010Research and Development Astex, UCB, appointment, research and development
Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …
Sanofi signs deal on pre-clinical cancer drugs
June 4, 2010Research and Development Cancer, Sanofi
Sanofi-Aventis has signed a deal with US biotech company Ascenta to co-develop new oncology treatments aimed at restoring ‘apoptosis’ or …
ASCO cancer conference opens
June 4, 2010Research and Development ASCO, Cancer, lenalidomide, rituximab
One of the most important dates in the pharmaceutical industry’s calendar, the ASCO cancer conference begins today. The American Society …
Vaccine for brain cancer shows promise
June 3, 2010Research and Development Cancer, GBM, ImmunoCellular
Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …
NICE rejects Xolair for children
June 3, 2010Sales and Marketing NICE, Xolair, asthma
The drug was first approved in Europe in November 2005 for patients aged 12 or older, and gained NICE approval …
Ogilvy wins Pradaxa account
June 3, 2010Medical Communications Boehringer, Ogilvy, Pradaxa
Boehringer Ingelheim has awarded OgilvyHealthPR the global communications brief for its oral blood-thinner Pradaxa. The agency was appointed after a …
Erbitux ‘now standard of care’ in KRAS patients
June 3, 2010Sales and Marketing Erbitux, Merck Serono
A new survey suggests Merck Serono’s Erbitux has become a standard of care for KRAS wild-type metastatic colorectal cancer The …
Teva staff in Ireland vote for industrial action
June 3, 2010Manufacturing and Production Ireland, Teva
Workers at a plant operated by Teva in Ireland have voted to take industrial action in a dispute over redundancy …
Pfizer launches iPhone service for doctors
June 3, 2010Medical Communications Apple, Epocrates, Pfizer, digital doctors, emedicine, iphone
A new service to allow doctors to communicate with Pfizer via iPhones and other mobile devices has been unveiled. Clinicians …
Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre
June 3, 2010Research and Development
Chiltern will draw upon many parts of TAHSC, including the Clinical Research Centre (CRC) which is located on the same …
Leo chooses Cegedim for Asia Pacific
June 2, 2010Business Services Asia, CRM
Leo Pharma has chosen a Cegedim Dendrite CRM system for its sales teams in Asia Pacific. ‘Mobile Intelligence’ is a …
Thalidomide recommended ahead of Velcade
June 2, 2010Medical Communications NICE, myeloma
Celgene’s Thalidomide has been recommended by NICE as a treatment for multiple myeloma, and is favoured ahead of Janssen-Cilag’s Velcade. …
Xeloda for gastric cancer gains NICE nod
June 2, 2010Sales and Marketing UK, Xeloda
NICE has recommended Roche’s Xeloda as a first line treatment of inoperable advanced gastric cancer.The cost-effectiveness body says the oral …
Tim Mustill joins Acumed
June 2, 2010Medical Communications Acumed, KnowledgePoint360, appointment, medical communications
Tim Mustill has been appointed vice-president of client services at Acumed, part of the KnowledgePoint360 medical communications group. He has …
Amgen’s Prolia approved in Europe
June 1, 2010Sales and Marketing Amgen, Prolia
A blockbuster future is predicted for the osteoporosis treatment Prolia, with global sales predicted to reach $5 billion.European regulators have …
Global MS awareness campaign launched
June 1, 2010Medical Communications MS, Merck Serono
Merck Serono has launched a short film competition as part of a global campaign, Real MS, to raise awareness of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
